Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer
Authors
Keywords
-
Journal
CANCER LETTERS
Volume 579, Issue -, Pages 216479
Publisher
Elsevier BV
Online
2023-11-03
DOI
10.1016/j.canlet.2023.216479
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification and characterization of a first-generation inhibitor of claudin-1 in colon cancer progression and metastasis
- (2023) Iram Fatima et al. BIOMEDICINE & PHARMACOTHERAPY
- Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells
- (2023) Sara Cherradi et al. Cell and Bioscience
- Inorganic pyrophosphatase 1 activates the phosphatidylinositol 3-kinase/Akt signaling to promote tumorigenicity and stemness properties in colorectal cancer
- (2023) Tianbao Niu et al. CELLULAR SIGNALLING
- Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis
- (2022) Mark Primeaux et al. CLINICAL & EXPERIMENTAL METASTASIS
- UALCAN: An update to the integrated cancer data analysis platform
- (2022) Darshan Shimoga Chandrashekar et al. NEOPLASIA
- Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients
- (2022) Lifeng Chen et al. Frontiers in Oncology
- The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
- (2022) Elmer Zapata-Mercado et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Treatment of HCC with Claudin-1 specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment
- (2022) Natascha Roehlen et al. JOURNAL OF HEPATOLOGY
- Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance
- (2022) Lucien Torlot et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity
- (2022) Natascha Roehlen et al. Science Translational Medicine
- Pan-claudin family interactome analysis reveals shared and specific interactions
- (2022) Lorena Suarez-Artiles et al. Cell Reports
- Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling
- (2021) Hao Wang et al. Cell Reports
- Epigenetic Regulation of Claudin-1 in the Development of Ovarian Cancer Recurrence and Drug Resistance
- (2021) Zachary R. Visco et al. Frontiers in Oncology
- A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients
- (2021) Saiprasad Gowrikumar et al. Cells
- Context-Dependent Roles of Claudins in Tumorigenesis
- (2021) Jian Li Frontiers in Oncology
- Targeting EphA2 in cancer
- (2020) Ta Xiao et al. Journal of Hematology & Oncology
- PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
- (2020) Rui Liu et al. Cell Death & Disease
- EPHA2 is a predictive biomarker of resistance and a potential therapeutic target for improving anti-epidermal growth factor receptor therapy in colorectal cancer.
- (2019) Giulia Martini et al. MOLECULAR CANCER THERAPEUTICS
- FOLFOX and FOLFIRI Use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data
- (2019) Alfred I. Neugut et al. Clinical Colorectal Cancer
- Upregulated claudin-1 expression promotes colitis-associated cancer by promoting β-catenin phosphorylation and activation in Notch/p-AKT-dependent manner
- (2019) Saiprasad Gowrikumar et al. ONCOGENE
- The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
- (2019) Zhenpeng Wang et al. Frontiers in Oncology
- Eph receptor signalling: from catalytic to non-catalytic functions
- (2019) Lung-Yu Liang et al. ONCOGENE
- Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy
- (2019) Sung Pil Hong et al. Nature Communications
- Decrease in paracellular permeability and chemosensitivity to doxorubicin by claudin-1 in spheroid culture models of human lung adenocarcinoma A549 cells
- (2018) Risa Akizuki et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay
- (2018) Lei Zhou et al. CELL BIOLOGY AND TOXICOLOGY
- Antibody targeting of claudin-1 as a potential colorectal cancer therapy
- (2017) S. Cherradi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- In Colon Epithelia, Clostridium perfringens Enterotoxin Causes Focal Leaks by Targeting Claudins Which are Apically Accessible Due to Tight Junction Derangement
- (2017) Miriam Eichner et al. JOURNAL OF INFECTIOUS DISEASES
- CLDN1 Increases Drug Resistance of Non-Small Cell Lung Cancer by Activating Autophagy via Up-Regulation of ULK1 Phosphorylation
- (2017) Zhenhuan Zhao et al. MEDICAL SCIENCE MONITOR
- Claudin-1 promotes TNF-α-induced epithelial-mesenchymal transition and migration in colorectal adenocarcinoma cells
- (2016) Ajaz A. Bhat et al. EXPERIMENTAL CELL RESEARCH
- Mechanisms of drug resistance in colon cancer and its therapeutic strategies
- (2016) Tao Hu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer
- (2015) P. D. Dunne et al. CLINICAL CANCER RESEARCH
- EphrinA2 Receptor (EphA2) Is an Invasion and Intracellular Signaling Receptor for Chlamydia trachomatis
- (2015) Prema Subbarayal et al. PLoS Pathogens
- Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling
- (2013) Jillian L Pope et al. GUT
- Claudins and the Modulation of Tight Junction Permeability
- (2013) Dorothee Günzel et al. PHYSIOLOGICAL REVIEWS
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner
- (2012) Amar B. Singh et al. CARCINOGENESIS
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters
- (2011) Junlin Li et al. BMC CANCER
- The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance
- (2011) Jan S. Moreb et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Claudin-1 Up-regulates the Repressor ZEB-1 to Inhibit E-Cadherin Expression in Colon Cancer Cells
- (2011) Amar B. Singh et al. GASTROENTEROLOGY
- Identification of Key Players for Colorectal Cancer Metastasis by iTRAQ Quantitative Proteomics Profiling of Isogenic SW480 and SW620 Cell Lines
- (2011) Dipanjana Ghosh et al. JOURNAL OF PROTEOME RESEARCH
- Colorectal cancer
- (2010) David Cunningham et al. LANCET
- Claudin Family of Proteins and Cancer: An Overview
- (2010) Amar B. Singh et al. Journal of Oncology
- EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
- (2009) Hui Miao et al. CANCER CELL
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
- (2009) Yifang Hu et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Identification and Functional Analysis of Phosphorylated Tyrosine Residues within EphA2 Receptor Tyrosine Kinase
- (2008) Wei Bin Fang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started